default author photo

Young-Hyuck Im

Sungkyunkwan University - Division of Hematology-Oncology

Seoul

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

118

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

Number of pages: 90 Posted: 10 Jul 2019
Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Oncology, Ajou University - School of Medicine, National Cancer Center, Korea, Seoul National University - Department of Internal Medicine, Ewha Womans University, Gachon University - Department of Internal Medicine, Inha University - Department of Internal Medicine, Chung-Ang University, College of Medicine, Department of Internal Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Hematology and Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Yonsei Cancer Center, University of Ulsan - Department of Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology and Seoul National University - Department of Internal Medicine
Downloads 118 (604,538)

Abstract:

Loading...

HR-positive, HER2-negative metastatic breast cancer; premenopausal women; palbociclib, exemestance, capecitabine